(Updates with additional information throughout from Nourish's press release and removes Market Chatter tag.)
Nourish, a nutrition counseling startup focused on supporting patients using GLP-1 weight-loss drugs, raised $100 million in a Series C funding round led by Menlo Ventures, the company said Tuesday.
The round included participation from Thrive Capital, Index Ventures, JPMorgan Chase's (JPM) growth equity arm, Maverick Ventures, Y Combinator and others, the company said.
Nourish said the financing increased its total funding to $215 million and will support expansion of its clinical network, artificial intelligence tools for patients and providers, and metabolic clinic model.
JPMorgan Chase did not immediately respond to' request for comment.
Price: $299.33, Change: $-1.43, Percent Change: -0.48%